Hiraoka H, Yamashita S, Matsuzawa Y, Kubo M, Nozaki S, Sakai N, Hirano K, Kawata S, Tarui S
Second Department of Internal Medicine, Osaka University Medical School, Japan.
Hepatology. 1993 Jul;18(1):103-10.
Serum levels of high-density lipoprotein cholesterol are often increased in patients with primary biliary cirrhosis. To elucidate the mechanism of the elevation of high-density lipoprotein cholesterol levels in this disease, lipoprotein abnormalities were analyzed in 10 patients subdivided into two groups according to concentration of high-density lipoprotein cholesterol. Activities and protein masses of lipoprotein lipase, hepatic triglyceride lipase and cholesteryl ester transfer protein were also determined. Serum high-density lipoprotein cholesterol concentration exceeded 90 mg/dl in 5 of 10 patients. Lipoprotein particles in the high-density lipoprotein2 fraction (with density between 1.063 and 1.125 gm/ml) were enriched with apolipoprotein E and larger in size than those of normal controls. In patients with and without hyperalphalipoproteinemia, hepatic triglyceride lipase activity was significantly decreased (p < 0.05); this was due to the reduction of its protein mass. Lipoprotein lipase activity and protein mass were normal. It is noteworthy that increases in cholesteryl ester transfer protein activity and mass were observed. The enhancement of cholesteryl ester transfer protein activity was more remarkable in the patients with hyperalphalipoproteinemia than in those without hyperalphalipoproteinemia. Because a significant positive correlation was demonstrated between activity and protein mass (r = 0.90, p < 0.001), the increase of cholesteryl ester transfer protein activity may be attributed to the increase of its protein mass. These data suggest that the decrease of hepatic triglyceride lipase levels at least partly explains the appearance of apolipoprotein E-rich large high-density lipoprotein particles in patients with primary biliary cirrhosis.(ABSTRACT TRUNCATED AT 250 WORDS)
原发性胆汁性肝硬化患者的血清高密度脂蛋白胆固醇水平常升高。为阐明该疾病中高密度脂蛋白胆固醇水平升高的机制,根据高密度脂蛋白胆固醇浓度将10例患者分为两组,分析其脂蛋白异常情况。同时还测定了脂蛋白脂肪酶、肝甘油三酯脂肪酶和胆固醇酯转运蛋白的活性及蛋白量。10例患者中有5例血清高密度脂蛋白胆固醇浓度超过90mg/dl。高密度脂蛋白2组分(密度在1.063至1.125g/ml之间)中的脂蛋白颗粒富含载脂蛋白E,且尺寸大于正常对照组。无论有无高α脂蛋白血症,患者的肝甘油三酯脂肪酶活性均显著降低(p<0.05),这是由于其蛋白量减少所致。脂蛋白脂肪酶的活性和蛋白量正常。值得注意的是,观察到胆固醇酯转运蛋白的活性和量均增加。高α脂蛋白血症患者中胆固醇酯转运蛋白活性的增强比无高α脂蛋白血症患者更显著。由于活性与蛋白量之间存在显著正相关(r=0.90,p<0.001),胆固醇酯转运蛋白活性的增加可能归因于其蛋白量的增加。这些数据表明,肝甘油三酯脂肪酶水平的降低至少部分解释了原发性胆汁性肝硬化患者中富含载脂蛋白E的大高密度脂蛋白颗粒的出现。(摘要截断于250字)